GBP1 and cervical carcinoma: Drug sensitivity analysis showed that the expression of GBP1 was positively correlated with the IC50 (half maximal inhibitory concentration) of eight drugs, including Cediranib, BLU-667 and JNJ-42756493, that is, as the expression of GBP1 increased, the stronger the resistance of cervical cancer cells to drugs.